4-[[5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-butanoic Acid Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

4-?[[5-?[[(1,?1-?Dimethylethoxy)?carbonyl]?amino]?pentyl]?(phenylmethoxy)?amino]?-?4-?oxo-butanoic Acid is an intermediate in synthesizing Deferoxamine-d7 TFA Salt (D228982), a labelled Deferoxamine Mesylate (D228980), which is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients.

4-[[5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-butanoic Acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

4-[[5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-butanoic Acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Beijing Taihe Jingming Pharmaceutical Technology Co., Ltd.	15011440205	chem_w@163.com	China	304	58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd	18162595016; 18162595016	3287908757@qq.com	China	9122	58

---

• 4-[[5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-butanoic Acid
• Butanoic acid, 4-[[5-[[(1,1-dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-
• 5-(Benzyloxy)-11-(tert-butoxycarbonyl)-4-oxo-5,11-diazaundecanoic acid
• Xanthoanthrafil Impurity 2
• 153492-12-7